By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Galapagos NV 

Industriepark Mechelen Noord I, Zone L
Generaal De Wittelaan 11 A
Mechelen    B-2800  Belgium
Phone: 32-15-34-29-00 Fax: 32-15-34-29-01



Company News
Galapagos (GLPG.BR) Release: Patient Recruitment Completed In FITZROY Phase 2 Crohn's Disease Study With Filgotinib 8/6/2015 8:33:00 AM
Galapagos (GLPG.BR) On Track To Deliver On Pipeline In Second Half 2015 8/6/2015 8:22:02 AM
Galapagos (GLPG.BR)' Selective JAK1 Inhibitor Filgotinib Meets Key Efficacy Endpoints, Shows ACR70 Responses Up To 39%, And Maintains Safety Profile After 24 Weeks Of Treatment In DARWIN 1 Phase 2B Study 7/30/2015 8:57:06 AM
Galapagos (GLPG.BR) Licenses Organoid Technology From The HUB Foundation For Use In Cystic Fibrosis And IBD Research 7/15/2015 11:31:02 AM
Galapagos (GLPG.BR) Raises €4.4 Million Through Warrant Exercises 6/22/2015 8:46:03 AM
Galapagos (GLPG.BR) Completes Recruitment For ORIGIN Phase 2 Trial With GLPG1205 In Ulcerative Colitis Patients 6/18/2015 9:36:52 AM
AbbVie (ABBV) And Galapagos (GLPG.BR) Present Cystic Fibrosis Corrector And Potentiator Screening Approach At ECFS Conference 6/15/2015 9:29:26 AM
Galapagos (GLPG.BR) DARWIN 1 And 2 Studies Have Completed 24 Weeks Of Treatment 6/10/2015 8:26:52 AM
BIOCITECH: Galapagos (GLPG.BR) Signs Long-Term Lease For One-Third Of The Park’s Space 6/2/2015 11:34:10 AM
Galapagos (GLPG.BR) Receives Transparency Notifications 5/26/2015 2:12:55 PM